Paydirt
Insider filing · NGNE

Christine Mikail Cvijic sold $300K of Neurogene (NGNE)

Executed May 6, disclosed May 8, 2 days later.

Value, as filed
$300K
9,600 sh across 2 lots
Executed
May 6
the trade date, as filed
Disclosed
May 8
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only

Returns are measured on stock purchases only.

The filer
CC Christine Mikail Cvijic President and CFO profile →

Christine Mikail Cvijic (President and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurogene Inc. (NGNE). The largest single filing was $300K of NGNE (9,600 sh across 2 lots, as filed), executed May 6.

The name
NGNE Neurogene Inc. NGNE · Healthcare · 7 filings in 24 months ticker →

Healthcare · Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Christine Mikail Cvijic in NGNE
NGNESALE Neurogene Inc. $152K
4,200 sh × $36.13
Exec Jul 7
Filed Jul 7 · 9:08 PM ET NGNESALE Neurogene Inc. $121K
4,800 sh × $25.11
Exec Feb 27
Filed Mar 3 · 5:30 PM ET NGNEPURCHASE Neurogene Inc. $492K
24,000 sh × $20.48
Exec Nov 22 2024
Filed Nov 25 2024 · 5:30 PM ET